Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Preiser

Showing results (61-70 of 63) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 63 results.
Vox Sanguinis|July 9, 2002
Prevention of post-transfusion cytomegalovirus: leucoreduction or screening?H W Reesink, C P Engelfriet, G E Tegtmeier, et al.
Nature Communications|March 5, 2024
Frequency, kinetics and determinants of viable SARS-CoV-2 in bioaerosols from ambulatory COVID-19 patients infected with the Beta, Delta or Omicron variantsS Jaumdally, M Tomasicchio, A Pooran, et al.
African Journal of Thoracic and Critical Care Medicine|November 4, 2021
A position statement and practical guide to the use of particulate filtering facepiece respirators (N95, FFP2, or equivalent) for South African health workers exposed to respiratory pathogens including <i>Mycobacterium tuberculosis</i> and SARS-CoV-2K Dheda, S Charalambous, A S Karat, et al.
Pageof 7

Showing results (61-70 of 63) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 63 results.
Vox Sanguinis|July 9, 2002
Prevention of post-transfusion cytomegalovirus: leucoreduction or screening?H W Reesink, C P Engelfriet, G E Tegtmeier, et al.
Nature Communications|March 5, 2024
Frequency, kinetics and determinants of viable SARS-CoV-2 in bioaerosols from ambulatory COVID-19 patients infected with the Beta, Delta or Omicron variantsS Jaumdally, M Tomasicchio, A Pooran, et al.
African Journal of Thoracic and Critical Care Medicine|November 4, 2021
A position statement and practical guide to the use of particulate filtering facepiece respirators (N95, FFP2, or equivalent) for South African health workers exposed to respiratory pathogens including <i>Mycobacterium tuberculosis</i> and SARS-CoV-2K Dheda, S Charalambous, A S Karat, et al.
Pageof 7